Terms: = Bone cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
1021 results:
1. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
[TBL] [Abstract] [Full Text] [Related]
2. [Obesity and risk of relapse in patients with Acute Lymphoblastic Leukemia: A retrospective study].
Ramos-Peñafiel CO; Bejarano-Rosales MP; Gallardo-Rodríguez AG; Pérez-Sámano D; Leyton-Rivera HR; Olarte-Carrillo I; Martínez-Tovar A; Tarlovsky VF; Barranco-Lampón G; Alvarez-Altamirano K
Rev Med Chil; 2023 May; 151(5):600-609. PubMed ID: 38687542
[TBL] [Abstract] [Full Text] [Related]
3. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
[TBL] [Abstract] [Full Text] [Related]
5. Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy.
Jia X; Liao N; Yao Y; Guo X; Chen K; Shi P
Cancer Biol Ther; 2024 Dec; 25(1):2323765. PubMed ID: 38465622
[TBL] [Abstract] [Full Text] [Related]
6. Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
Elbnnani AS; Elbasir M; Altabal S; Lamami Y; Ebrahim F; Oshah HM; Alagnef R; Elzagheid A; Abulayha AM
Libyan J Med; 2024 Dec; 19(1):2319895. PubMed ID: 38394044
[TBL] [Abstract] [Full Text] [Related]
7. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
Lee MH; Song A; Li JY
Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating testicular tissue for future autotransplantation: focus on cancer cell contamination and presence of spermatogonia in tissue cryobanked for boys diagnosed with a hematological malignancy.
Kourta D; Camboni A; Saussoy P; Kanbar M; Poels J; Wyns C
Hum Reprod; 2024 Mar; 39(3):486-495. PubMed ID: 38227814
[TBL] [Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.
Sadowska-Klasa A; Zaucha JM; Labopin M; Bourhis JH; Blaise D; Yakoub-Agha I; Salmenniemi U; Passweg J; Fegueux N; Schroeder T; Giebel S; Brissot E; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Mar; 59(3):387-394. PubMed ID: 38195982
[TBL] [Abstract] [Full Text] [Related]
10. Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (cml-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric cml (pcml) cohort.
Roy Moulik N; Keerthivasagam S; Pandey A; Agiwale J; Hegde K; Chatterjee G; Dhamne C; Prasad M; Chichra A; Srinivasan S; Mohanty P; Jain H; Shetty D; Tembhare P; Patkar N; Narula G; Subramanian PG; Banavali S
Br J Haematol; 2024 Apr; 204(4):1249-1261. PubMed ID: 38098201
[TBL] [Abstract] [Full Text] [Related]
11. Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia.
Boris E; Theron A; Montagnon V; Rouquier N; Almeras M; Moreaux J; Bret C
Cytometry B Clin Cytom; 2024 Jan; 106(1):45-57. PubMed ID: 38037221
[TBL] [Abstract] [Full Text] [Related]
12. CDC-NET: a cell detection and confirmation network of bone marrow aspirate images for the aided diagnosis of AML.
Su J; Liu Y; Zhang J; Han J; Song J
Med Biol Eng Comput; 2024 Feb; 62(2):575-589. PubMed ID: 37953336
[TBL] [Abstract] [Full Text] [Related]
13. CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
Buldini B; Faggin G; Porcù E; Scarparo P; Polato K; Tregnago C; Varotto E; Rizzardi P; Rizzari C; Locatelli F; Biffi A; Pigazzi M
Cytometry A; 2023 Dec; 103(12):1004-1009. PubMed ID: 37876342
[TBL] [Abstract] [Full Text] [Related]
14. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract] [Full Text] [Related]
15. Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.
Wu A; Yen R; Grasedieck S; Lin H; Nakamoto H; Forrest DL; Eaves CJ; Jiang X
Leukemia; 2023 Dec; 37(12):2426-2435. PubMed ID: 37848633
[TBL] [Abstract] [Full Text] [Related]
16. Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients.
Aldapt MB; Al-Mashdali AF; Obeidat K; Chandra P; Yassin M
Oncology; 2024; 102(4):380-388. PubMed ID: 37848004
[TBL] [Abstract] [Full Text] [Related]
17. FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
Kowarsch F; Maurer-Granofszky M; Weijler L; Wödlinger M; Reiter M; Schumich A; Feuerstein T; Sala S; Nováková M; Faggin G; Gaipa G; Hrusak O; Buldini B; Dworzak MN
Cytometry A; 2024 Jan; 105(1):24-35. PubMed ID: 37776305
[TBL] [Abstract] [Full Text] [Related]
18. NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia.
Ulvmoen A; Greiff V; Bechensteen AG; Inngjerdingen M
J Leukoc Biol; 2024 Jan; 115(2):334-343. PubMed ID: 37738462
[TBL] [Abstract] [Full Text] [Related]
19. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.
Caserta C; Nucera S; Barcella M; Fazio G; Naldini MM; Pagani R; Pavesi F; Desantis G; Zonari E; D'Angiò M; Capasso P; Lombardo A; Merelli I; Spinelli O; Rambaldi A; Ciceri F; Silvestri D; Valsecchi MG; Biondi A; Cazzaniga G; Gentner B
Leukemia; 2023 Oct; 37(10):1994-2005. PubMed ID: 37640845
[TBL] [Abstract] [Full Text] [Related]
20. diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
[Next]